FDA Expands Evinacumab-dgnb Approval for Children as Young as 1 Year With HoFH
Evinacumab-dgnb approval expands treatment options for children with homozygous familial hypercholesterolemia (HoFH).
Read More
Hematology Survivorship Care Lags Behind Therapeutic Innovations: Brian Koffman, MDCM, DCFP, FCFP, DABFP, MSEd
Patients with hematologic malignancies face ongoing survivorship challenges as providers struggle to coordinate care, according to Brian Koffman, MDCM, DCFP, FCFP, DABFP, MSEd.
Watch
Paltusotine FDA Approved for Acromegaly in Adults
The approval of paltusotine (Palsonify; Crinetics) marks the first for a once-daily, oral therapy to treat acromegaly.
Individualizing Treatment for Patients With AML Unfit for Intensive Chemo
The evolving treatment landscape for unfit patients with newly diagnosed acute myeloid leukemia (AML) centers on venetoclax combination and personalized strategies.
In Primary Care–Oncology Collaboration, the Baton Goes Both Ways
Panelists discussed the ingredients of successful handoffs at the time of cancer diagnosis and ways to collaborate as screening capabilities evolve.
FDA Approves Imlunestrant for ER+ and HER2-Negative Breast Cancer
FDA approved the monotherapy for estrogen receptor (ER)–positive and HER2-negative metastatic breast cancer.
Strong Advocacy Helps Address Barriers in Modern Oncology Care: Sucharu "Chris" Prakash, MD
Consolidation in oncology is creating access and cost challenges, whereas advocacy helps improve patient care and treatment availability, according to Sucharu "Chris" Prakash, MD.
Reducing Frustration in Oncology Utilization Management Through Payer, Provider Collaboration: Vishnukamal Golla, MD, MPH
Oncology utilization management often frustrates patients and payers, but collaboration and artificial intelligence can streamline processes and improve care quality, according to Vishnukamal Golla, MD, MPH.
Dr Anders Kolb on Leading Blood Cancer United Into a New Era
Blood Cancer United, formerly Leukemia & Lymphoma Society, aims to enhance awareness and support for blood cancer patients during Blood Cancer Awareness Month.
Listen
Information and Integration Can Take Oncology Patients From Surviving to Thriving
As therapeutic advances enable patients with cancer to live longer, greater attention is needed to support the goal of survivorship, starting at diagnosis.
Marathon Health, Medbridge Partner to Launch Integrated Virtual MSK Care Program
The program works by embedding Medbridge’s Pathways platform into Marathon’s MoveWell MSK program and advanced primary care model.
Myasthenia Gravis–Induced Fears of Diagnosed Patients During the Pandemic
Patients with myasthenia gravis had more COVID-19–related anxieties due to their diagnosis and immunosuppressive therapies.
Simple Retrieval Step Boosts AI Accuracy in Assigning ICD Codes
Researchers found that even smaller open artificial intelligence (AI) models outperformed clinicians, supporting automation of International Classification of Disease (ICD) coding.
Supporting Pharmacy Residents in Completing Research Projects at UC Davis: Jeremiah J. Duby, PharmD, BCPS, BCCCP
Jeremiah J. Duby, PharmD, BCPS, BCCCP, describes supporting pharmacy residents at the University of California (UC), Davis, in his role as a research advisor.
Complications Most Common in Children With Early-Onset, Chronic Uveitis
Children who had chronic, early-onset, nonanterior uveitis were at an increased risk of developing other complications surrounding the eye.
Contributor: Medication Adherence as a Journey—A Year-Round Strategy for Medicare Advantage Success
Adherence can lead to better outcomes, higher starts for Medicare Advantage plans, and stronger financial performance.
US, Japan Patients With Diabetes Discontinue Semaglutide After First Year
High discontinuation rates of semaglutide among older adults with diabetes reveal challenges in long-term adherence and highlight the need for improved support strategies.
Childhood Insurance Dynamics Predict Medicaid Cuts Will Widen Gaps
Proposed Medicaid cuts threaten children's health coverage, exacerbating existing gaps and impacting access to care for vulnerable populations.
Study Finds No Causal Link Between Coffee Consumption, Arthritis Risk
The relationship between caffeine and rheumatoid arthritis has been inconsistent across prior studies.
Rolling Back PrEP Coverage Affects Both New Infections, Economic Cost: Patrick Sullivan, DVM, PhD
Any potential reduction in access to pre-exposure prophylaxis (PrEP) would increase both cost and the number of diagnoses of HIV.
Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review
Leucovorin is under FDA review to expand treatment for children with cerebral folate deficiency, which has been assciated with autism.
Debating Hazards, Exploring Solutions: Key Themes at the ERS Congress 2025
Discover groundbreaking discussions at the European Respiratory Society Congress 2025, focusing on severe asthma, e-cigarette debates, and global health equity in respiratory care.
Retail Pharmacies Offer Accessible Means of Obtaining Medications: Mark Riggle, PharmD
The availability of retail pharmacies throughout the country have changed the health system in terms of accessibility and treatment, explains Mark Riggle, PharmD.
Finding Harmony in Oncology Innovation, Patient-Centered Care at PCOC 2025
Patient-Centered Oncology Care (PCOC) conference co-chairs Kathy Oubre, MS, and Davey Daniel, MD, explain how the event unites experts to explore evolving oncology care and patient-centered strategies.
Teclistamab for R/R MM Effective and Safe When Administered in a Community Setting
Teclistamab shows promising real-world effectiveness and safety in older adults with relapsed/refractory multiple myeloma (R/R MM), matching clinical trial outcomes.
Near Low–Income Medicare Beneficiaries Face More Affordability Problems Than Other Income Groups
Medicare beneficiaries with near low income experience more affordability issues than beneficiaries with low income due to Medicare savings programs eligibility.
Subtle Brain Changes May Drive Disability in Multiple Sclerosis Beyond Visible Lesions
New research reveals that changes in normal-appearing white and gray matter significantly impact MS progression, challenging traditional lesion-focused views.
Key Signatures, Potential Vulnerabilities of SCLC Identified
A new report identified 11 additional high-frequency mutations in small-cell lung cancer.
Autophagy Variants Linked With Increased Risk of CLL
Four autophagy-related variants in CDKN2A and BCL2 may increase susceptibility to chronic lymphocytic leukemia (CLL).
Nicotinamide Reduces New Skin Cancer Risk in Large Veteran Study
Oral nicotinamide reduced the risk of new skin cancers—especially squamous cell carcinoma—by up to 54% when started after a first diagnosis.
